Table II. Summary of percentage... | Rockefeller University Press

Table II.

Summary of percentage tumor-free mice at endpoint of experiment described in Fig. 2

Treatment group	Tumor-free /total mice replicate 1	Tumor-free /total mice replicate 2	Combined percent tumor free	Statistical significance
Treatment group	Tumor-free /total mice replicate 1	Tumor-free /total mice replicate 2	Combined percent tumor free	versus 6 × 10⁶	versus 0	versus naive
10³	11 / 14	12 / 16	77%	P < 0.01	P < 0.001^a	P < 0.001^a
10⁵	11 / 15	14 / 16	81%	P < 0.01	P < 0.001^a	P < 0.001^a
10⁶	10 / 15	9 / 16	52%		P < 0.05	P < 0.001^a
6 × 10⁶	5 / 12	5 / 15	37%
0 (no pmel)	6 / 14	2 / 15	28%
Naive	1 / 10	3 / 15	16%

Treatment group	Tumor-free /total mice replicate 1	Tumor-free /total mice replicate 2	Combined percent tumor free	Statistical significance
Treatment group	Tumor-free /total mice replicate 1	Tumor-free /total mice replicate 2	Combined percent tumor free	versus 6 × 10⁶	versus 0	versus naive
10³	11 / 14	12 / 16	77%	P < 0.01	P < 0.001^a	P < 0.001^a
10⁵	11 / 15	14 / 16	81%	P < 0.01	P < 0.001^a	P < 0.001^a
10⁶	10 / 15	9 / 16	52%		P < 0.05	P < 0.001^a
6 × 10⁶	5 / 12	5 / 15	37%
0 (no pmel)	6 / 14	2 / 15	28%
Naive	1 / 10	3 / 15	16%

Endpoint was day 104 (replicate 1) and day 131 (replicate 2) post-tumor challenge. Statistical significance was calculated for combined experiment.

Indicates values remaining significant after correction for multiple comparisons.